Abstract
The experience of Connaught Labs offers lessons for Canada's new Sanofi deal to manufacture vaccines in Canada, and it doesn't appear the government has learned much from it.
Original language | Canadian English |
---|---|
Publication status | Published - Jan. 1 2021 |
Keywords
- Vaccines
- Vaccine Manufacturing
- Canada
Disciplines
- Food and Drug Law
- Health Law and Policy
- Law
- Science and Technology Law